Electronic data capture for early-stage trials: Phase 1–2 flexibility, safety and efficacy, and 21 CFR Part 11–aligned controls without enterprise overhead.
21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required
Early-stage sponsors rarely run a single trial; more often they have a pipeline of related Phase 1 and Phase 2 studies, investigator-initiated research, and exploratory projects. Capture is designed so that study builders can keep a library of proven designs—consent flows, visit structures, and CRFs—and then adapt them quickly when a new protocol is ready. This reduces the overhead of launching each new study while keeping audit trails and validation activities aligned with your SOPs.
On the operational side, early-stage teams use Capture in ways that mirror what you see on the marketing site and demo page: study builders configure designs through the browser, site users access visit-based CRFs and eConsent flows, and monitors and data managers work from the same underlying dataset. Because the platform is modular, you can keep the environment simple for smaller or academic studies while enabling additional modules for more complex sponsor-led programs.
Overview
Early-stage clinical trials span Phase 1, 1a, 1b, and Phase 2—safety, PK, and early efficacy in smaller cohorts with frequent protocol iteration. Sponsors and CROs often run a portfolio of these studies across related assets or indications, reusing design patterns while still tailoring details to each protocol and site mix. In this environment, the bottleneck is rarely an individual feature; it is the time it takes to build, amend, validate, and support multiple studies in parallel without a large operations team. Your EDC must support rapid build and amendments, consent and safety workflows, and full auditability without the cost and complexity of systems built for Phase 3. It should make it easy to reuse successful designs as blueprints, standardize common forms and visit structures, and still provide the flexibility to adjust when new data or feedback from investigators suggests a change. It also needs to fit how early-stage teams actually work—often with part-time or cross-functional staff who split time between protocol design, site support, and data review—by providing a modern web interface and clear roles that don’t require a separate IT department to administer. Capture provides one platform for EDC, eConsent, ePRO, and safety with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure, so you can run early-stage trials from FIH through proof-of-concept without enterprise overhead and without maintaining multiple disjointed tools.
Early-stage studies share a need for agility: smaller teams, tighter budgets, and protocols that evolve as data comes in. You need an electronic data capture system that can be configured quickly, supports safety and efficacy workflows, and maintains audit trails and access controls suitable for regulatory scrutiny—without per-seat or per-module pricing that doesn’t scale with cohort size.
FAQ
Explore the platform with a free sandbox. No sales call required.